Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan flag Japan · Delayed Price · Currency is JPY
7,004.00
+26.00 (0.37%)
Oct 29, 2026, 3:30 PM JST

Kobayashi Pharmaceutical Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
167,473165,742165,600173,455166,258155,252
Revenue Growth
3.71%0.09%-4.53%4.33%7.09%3.15%
Gross Profit
84,89884,71287,60396,37692,33188,774
Operating Income
10,35914,84524,71025,62726,50625,951
Net Income
1,6253,65610,06720,33820,02219,715
Earnings Per Share
21.8649.18135.42268.16259.59252.35
EPS Growth
-86.23%-63.68%-49.50%3.30%2.87%2.71%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Others
6,5816,5117,0606,8446,758
International Business
48,41546,84144,13341,55431,140
Domestic Business (Incl. Mail Order Business)
122,920123,924136,539--
Unallocated Adjustment
-12,174-11,676-14,277-14,823-13,596
Total
165,742165,600173,455166,256155,252

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
57,32970,61465,74579,836104,533109,046
Total Debt
723678846987792630
Net Cash (Debt)
56,60669,93664,89978,849103,741108,416
Net Cash Growth
-17.87%7.76%-17.69%-23.99%-4.31%15.77%
Net Cash Per Share
761.47940.78873.031039.651344.981387.72

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
11,84425,59011,24618,36031,91422,419
Capital Expenditures
-17,800-13,253-26,056-12,756-14,747-3,663
Free Cash Flow
-5,95612,337-14,8105,60417,16718,756
Free Cash Flow Growth
----67.36%-8.47%-7.11%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
50.69%51.11%52.90%55.56%55.54%57.18%
Operating Margin
6.19%8.96%14.92%14.77%15.94%16.71%
Pretax Margin
1.02%2.26%8.40%15.89%16.81%17.80%
Profit Margin
0.97%2.21%6.08%11.72%12.04%12.70%
FCF Margin
-3.56%7.44%-8.94%3.23%10.33%12.08%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
106.000104.000102.000101.00090.00083.000
Dividend Per Share Growth
1.92%1.96%0.99%12.22%8.43%7.79%
Dividend Yield
1.51%1.92%1.64%1.49%1.05%0.92%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
320.41110.3746.0124.7732.4835.73
Forward PE
43.5930.3730.1124.5233.4634.40
P/FCF Ratio
-32.71-89.9137.8837.56
PS Ratio
3.112.442.802.913.914.54